Timeline focuses on promoting healthy aging through its proprietary ingredient, Mitopure®, which is derived from Urolithin A. This postbiotic has been extensively studied, with over 15 years of research and 11 human clinical trials involving more than 900 participants. Mitopure® is designed to enhance mitochondrial health, which is crucial for cellular energy production and overall well-being. The company emphasizes the importance of mitochondrial function in various aspects of health, including muscle strength, skin vitality, and cognitive function, highlighting its role in combating age-related decline.

The effectiveness of Mitopure® is supported by a robust scientific foundation, including more than 500 studies on Urolithin A and over 50 patents protecting its formulation. Timeline's products, such as their night cream and other skincare offerings, leverage the benefits of Mitopure® to promote cellular renewal and improve skin appearance. The company is committed to sustainability, utilizing refillable and recyclable packaging, and ensuring that their formulations are dermatologically tested and suitable for all skin types. Through these innovations, Timeline aims to provide high-performance products that contribute to healthier aging and improved quality of life.

Switzerland

Timeline (parent company Amazentis) is a Swiss longevity biotech positioned at the intersection of the consumer health, nutrition, and beauty sectors. With more than a decade of expertise in aging science research, Timeline seeks to push the boundaries of human healthspan, contributing to a future where everyone can live longer, healthier lives. The company is backed by over 15 years of research by distinguished scientists, multiple clinical studies, and over 50 patents. Nestlé Health Science and L'Oréal are investors in the company.

Timeline

Company Details